PATENT CLAIM ANALYSIS

Application Number: 15864494
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "227100"]

Abstract:
Provided are human antibodies that specifically bind to HBV Pre-S1 domain ligand and inhibit HBV or HDV infection, antibodies binding to a set of amino acid residues that are critical for viral receptor engagement, and uses of these antibodies to prevent, or treat or diagnose HBV or HDV infection.

Claim (Index 36):
The antibody, or antigen-binding fragment thereof of, of  claim 35 , wherein the antibody or antigen-binding fragment thereof binds an epitope on Pre-S1 comprising at least residues 20-27 of the 59C peptide.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.47222
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15766593', '12322861', '13466439', '14449478', '15302018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7591383589645172
- 35 USC 102 Novelty (BERT): 0.5270340536014397
- Combined Prediction Score: 0.7359279284282094
- Mean Citation Score: 341.3386900000001
- Max Citation Score: 354.49304
- Similarity Product: 260.6951610412264

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test